Skip to main content
LEAP THERAPEUTICS, INC. logo

LEAP THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LPTX ISIN · US52187K2006 LEI · 549300T31SMMJ2DDLI13 US Manufacturing
Filings indexed 584 across all filing types
Latest filing 2023-05-15 Earnings Release
Country US United States of America
Listing US LPTX

About LEAP THERAPEUTICS, INC.

https://www.leaptx.com/

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer. Its most advanced clinical candidate, DKN-01 (sirexatamab), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, being developed for patients with esophagogastric, gynecologic, and colorectal cancers. The company's pipeline also includes FL-301, a monoclonal antibody targeting Claudin18.2 for gastric and pancreatic cancer, and FL-501, a preclinical antibody targeting the growth and differentiation factor 15 (GDF-15) protein.

Recent filings

Filing Released Lang Actions
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 15, 2023, reporting the results of operations and financial condition for the quarter ended March 31, 2023. It includes a press release as an exhibit announcing the financial results. The text explicitly states that the full financial results are in the press release exhibit, and the 8-K itself is a current report announcing these results. The document is 4285 characters long, which is relatively short and consistent with an earnings release announcement rather than a full quarterly report. The Form 8-K is typically used for current event disclosures, including earnings releases. Therefore, this document is best classified as an Earnings Release (ER).
2023-05-15 English
ARS
Annual Report
2023-04-28 English
DEF 14A
Proxy Solicitation & Information Statement
2023-04-28 English
Regulatory Filings 2023
Regulatory Filings Classification · 95% confidence The provided document text appears to be heavily encoded or corrupted, containing no readable or meaningful content related to financial reporting, regulatory announcements, or corporate filings. There are no identifiable keywords, regulatory body references, fiscal period dates, or document titles that would allow classification into any specific filing category. The document length is 15,000 characters, which is substantial, but the content is not interpretable as a financial or corporate filing. Given the lack of any discernible information, the document best fits the fallback category for miscellaneous or unclassifiable filings, which is Regulatory Filings (RNS).
2023-04-27 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text mentions a press release about presenting updated data at a conference, and the press release is attached as an exhibit. There are no financial statements or detailed financial data included. The document is short (3883 characters) and primarily serves as an announcement of an event and a press release. According to the rules, such filings are classified as Regulatory Filings (RNS) because they do not contain full financial reports or detailed financial data but are regulatory announcements of events.
2023-04-26 English
S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used for registering securities for sale to the public. It includes detailed information about the offering, selling stockholders, use of proceeds, risk factors, and other disclosures typical of a securities registration statement. It is not an annual report, earnings release, or any other financial report but a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full registration statement, not just an announcement or notice.
2023-04-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.